Dow Up0.26% Nasdaq Up0.15%

IsoRay, Inc. (ISR)

1.58 Down 0.33(17.30%) 12:01PM EDT - Nasdaq Real Time Price
ProfileGet Profile for:
IsoRay, Inc.
350 Hills Street
Suite 106
Richland, WA 99354
United States - Map
Phone: 509-375-1202

Index Membership:N/A
Industry:Medical Instruments & Supplies
Full Time Employees:36

Business Summary 

IsoRay, Inc develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases primarily in the United States. The company produces Proxcelan Cesium-131 brachytherapy seeds that are used for the treatment of prostate, lung, head and neck, colorectal, brain, pelvic/abdominal, and gynecological cancers, as well as ocular melanoma. It also offers GliaSite radiation therapy system, a balloon catheter device, which is used to treat brain cancer, including primary and recurrent gliomas and metastic brain tumors. The company is based in Richland, Washington.

Key Statistics

Company Websites 
Home Page
Search Yahoo! for:
More on IsoRay, Inc.

Key Executives 
Mr. Dwight Babcock , 66
Chairman and Chief Exec. Officer
Mr. Fredric Swindler , 67
Mr. William Cavanagh III, 48
VP of R&D and VP of R&D for Isoray Medical Inc
Mr. Brien L. Ragle , 45
Chief Financial Officer, Principal Financial & Accounting Officer and Controller
Krista Cline ,
Corp. Sec.
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders